CTF in the NewsFeaturedNF1NF2-SWNSWN CTF President Annette Bakker Interviewed by MedPage Today for 3-Part Series
Collaborations & PartnershipsNF1Press ReleaseScience & Research SpringWorks Therapeutics Announces Positive Topline Results from the Phase 2b ReNeu Trial of Mirdametinib in NF1-PN